$Albireo Pharma, Inc.(ALBO)$ 

The closing of the tender offer will be subject to customary conditions, including the tender of shares which represent at least a majority of the total number of Albireo’s outstanding shares, the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and the receipt of consents of, or filings with, any governmental body or pursuant to certain foreign antitrust laws and the expiration of any applicable waiting period and other customary conditions. Upon the successful completion of the tender offer, Ipsen would acquire all shares not acquired in the tender offer through a second-step merger for the same consideration that the tendering stockholders will receive in the tender offer. It is anticipated the transaction will close by end of Q1, 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment42

  • Top
  • Latest
  • XantheJuliana
    ·2023-01-14
    Anyone notice ALBO? Nice move. 2023 is going to be the year for pharma.
    Reply
    Report
  • fishinglo
    ·2023-01-14
    MASSIVE order are coming in at the close, huge volume. Large institutions on the move again
    Reply
    Report
  • shining87
    ·2023-01-14
    ALBO will move up within 2 weeks. If it won't, then sell it and walk away
    Reply
    Report
  • k2000
    ·2023-01-12
    hao
    Reply
    Report
  • 十八顺
    ·2023-01-12
    [嘘]
    Reply
    Report
  • 薇红
    ·2023-01-12
    [微笑]
    Reply
    Report
  • Otahman
    ·2023-01-11
    Ok
    Reply
    Report
  • Skyjieni
    ·2023-01-11
    Waooo
    Reply
    Report
  • JWZ137
    ·2023-01-11
    wow
    Reply
    Report
  • Nchh
    ·2023-01-11
    Nice
    Reply
    Report
  • soun_garden
    ·2023-01-11
    Ok
    Reply
    Report
  • candyysk
    ·2023-01-11
    Ok
    Reply
    Report
  • BenGI
    ·2023-01-11
    cool
    Reply
    Report
  • Dindindino
    ·2023-01-11
    Ok
    Reply
    Report
  • firefirefire
    ·2023-01-11
    kk
    Reply
    Report
  • HLian
    ·2023-01-11
    ok
    Reply
    Report
  • Kwgan
    ·2023-01-11
    Ok
    Reply
    Report
  • kloopo
    ·2023-01-11
    from
    Reply
    Report
  • Blessedme
    ·2023-01-11
    noted
    Reply
    Report
  • ATH
    ·2023-01-11
    ok
    Reply
    Report